Audits of the prevention and treatment of corticosteroid-induced osteoporosis in outpatients with rheumatic diseases in the West Midlands

Clin Med (Lond). 2006 Mar-Apr;6(2):183-7. doi: 10.7861/clinmedicine.6-2-183.

Abstract

The management of corticosteroid-induced osteoporosis in rheumatology outpatients in the West Midlands was audited in relation to the 2002 Royal College of Physicians (RCP) Guidelines and re-audited in relation to the 1998 National Osteoporosis Society (NOS) Guidance. Practice was assessed from prospective data on all follow-up patients over a 2-week period in 13 rheumatology units. Data were analysed on 2,609 patients. Of the 626 patients fulfilling criteria for assessment against the RCP Guidelines, 351 (56.1%) were treated appropriately. The results do not allow for availability of, or wait for, DEXA scanning. Of 197 patients fulfilling the criteria for assessment against the NOS Guidance, 137 (69.5%) were treated appropriately, compared to 63% in a similar audit undertaken in 2000. Regional audit may facilitate clinical governance. These audits will inform discussion on both improving local practice and strengthening cases for improved osteoporosis services.

Publication types

  • Multicenter Study

MeSH terms

  • Adolescent
  • Adrenal Cortex Hormones / administration & dosage
  • Adrenal Cortex Hormones / adverse effects*
  • Adult
  • Aged
  • Aged, 80 and over
  • Bone Density
  • Female
  • Guideline Adherence*
  • Humans
  • Male
  • Medical Audit*
  • Middle Aged
  • Osteoporosis / chemically induced
  • Osteoporosis / therapy*
  • Outpatients
  • Practice Guidelines as Topic
  • Prednisolone / administration & dosage
  • Prednisolone / adverse effects
  • Prospective Studies
  • Rheumatic Diseases / drug therapy*
  • United Kingdom

Substances

  • Adrenal Cortex Hormones
  • Prednisolone